Blueprint Medicines' Ayvakyt gets approval in EU to treat systemic mastocytosis
March 25 2022 - 10:40AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
From Apr 2023 to Apr 2024